This indicates that deficiency of this crucial tumor suppressor might act cooperatively with therapeutic AR blockade to upregulate stress response pathways, which finally activate survival mechanisms of cancer cells via NF-κB-mediated induction of antiapoptotic genes. The gene discussed is NFKB1; the disease is cancer.